ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1614

Prevalence of Sonographic Enthesitis in Patients with Psoriasis without Arthritis and Its Association Risk Factors of Psoriatic Arthritis

Anwar Albasri1, Justine Y. Ye2, Cheryl F. Rosen3, Vinod Chandran2, Dafna D Gladman4 and Lihi Eder5, 1Rheumatology, University of Toronto, Toronto, ON, Canada, 2Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Department of Medicine, Toronto Psoriatic Arthritis Research Program, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 5Women's College Research Institute, University of Toronto, Women's College Hospital, Toronto, ON, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Enthesitis, psoriasis, Psoriatic arthritis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Enthesitis is one of the hallmarks of psoriatic arthritis (PsA) and may be the initial site of musculoskeletal inflammation. Enthesitis affects up to 50 % of patients with PsA and is a marker of more severe disease. However, clinical evaluation of enthesitis may be difficult. Ultrasound (US) is more sensitive than physical examination in detecting enthesitis. In patients with psoriasis alone (PsC) US can detect subclinical enthesitis which may predict future development of PsA. The aim of this study was to assess the association between the severity of sonographic enthesitis and risk factors for developing PsA. These risk factors include included obesity, severity of psoriasis, nail psoriasis in addition to physically demanding occupation and the presence musculoskeletal symptoms.

Methods: A cross-sectional study was conducted in patients with a dermatologist confirmed diagnosis of psoriasis. Each patient was assessed by a rheumatologist to exclude the presence of PsA. Information was collected about lifestyle habits, medical history, musculoskeletal symptoms and the skin activity using validated measures. The Madrid Sonography Enthesitis Index (MASEI) was used to quantify the severity of enthesitis in 12 entheseal sites. The sonographer was blinded to the clinical data. MASEI score³20 was considered as high score based on a previously validated cut-off in spondyloarthritis. Logistic regression analysis was used to assess the association between PsA-related risk factors and high MASEI score after adjusting for age, sex and BMI. The results were expressed as odds ratio (OR) and their 95 confident interval (CI).

Results: A total of 180 patients were studied. Of those, 52% were male with a mean age of 51.1±13.6 yrs. Majority of the patients (97%) didnÕt have tender entheseal site on the examination. The mean total MASEI score was 9.3±8.3 and high MASEI (³20) was found in 17 (9.4%) of the patients. The results of the regression analysis are shown in Table 1. Univariate regression analyses found an association between high MASEI score and Health Assessment Questionnaire (HAQ) (OR_14.8; P 0.006), the presence of morning stiffness (OR_=_ 4.7; P 0.009) physically demanding occupation (OR_=_ 5.5; P 0.01). The multivariable analysis showed that the presence of inflammatory back pain (OR 22.9, 95% CI 1.3, 401.8), morning stiffness (OR 5, 95% CI 1.03, 24.3), physically demanding occupation (OR 5.1, 1.01, 25.8) and HAQ (OR 13.9, 95% CI 1.02, 190.5) were associated with high MASEI.

Conclusion: In PsC patients, the severity of subclinical enthesitis was associated with occupational related physical stress and with inflammatory musculoskeletal complaints. Enthesitis might be playing a role in explaining the patients MSK complains in the absence of clinical features of PsA.

Table 1 Ð The association between high MASEI score (>=20) and PsA-related risk factors in patients with PsC by logistic regression multivariable analysis

Variable

Odds Ratio

95% Confidence Interval

P value

Age (years)

1.12

1.04, 1.21

0.002

Inflammatory back pain (yes)

22.98

1.31, 401.86

0.03

Morning stiffness (yes)

5.00

1.03, 24.29

0.045

Work class (physical occupation)

5.11

1.01, 25.78

0.048

HAQ

13.93

1.02, 190.46

0.048

Sex (Male)

2.08

0.36, 12.19

0.42

BMI

1.03

0.90, 1.17

0.67


Disclosure: A. Albasri, None; J. Y. Ye, None; C. F. Rosen, None; V. Chandran, None; D. D. Gladman, None; L. Eder, None.

To cite this abstract in AMA style:

Albasri A, Ye JY, Rosen CF, Chandran V, Gladman DD, Eder L. Prevalence of Sonographic Enthesitis in Patients with Psoriasis without Arthritis and Its Association Risk Factors of Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-sonographic-enthesitis-in-patients-with-psoriasis-without-arthritis-and-its-association-risk-factors-of-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-sonographic-enthesitis-in-patients-with-psoriasis-without-arthritis-and-its-association-risk-factors-of-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology